94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Marija Ilic1,2,3
Julian Maier1Marion Holy1Kathrin Jaentsch1
Matthias E. Liechti4
Gert Lubec3Michael H. Baumann5
Harald H. Sitte1*
Dino Luethi1,4- 1Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
- 2Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria
- 3Neuroproteomics, Paracelsus Private Medical University, Salzburg, Austria
- 4Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland
- 5Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, United States
by Ilic, M., Holy, M., Jaentsch, K., Liechti, M. E., Lubec, G., Baumann, M. H., Sitte, H. H., and Luethi, D. (2020). Front. Pharmacol. 11:673. doi: 10.3389/fphar.2020.00673
Julian Maier was not included as an author in the published article. The corrected Author Contributions appears below.
“MI, ML, GL, MB, HS, and DL designed the study. MI, JM, MH, KJ, and DL conducted the experiments. MI, MB, HS, and DL analyzed data. MI and DL wrote the manuscript with significant input from all other authors.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: monoamine, transporter, radiotracer, stimulant, synaptosomes, HEK 293
Citation: Ilic M, Maier J, Holy M, Jaentsch K, Liechti ME, Lubec G, Baumann MH, Sitte HH and Luethi D (2022) Corrigendum: Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters. Front. Pharmacol. 13:878641. doi: 10.3389/fphar.2022.878641
Received: 18 February 2022; Accepted: 22 February 2022;
Published: 16 March 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Ilic, Maier, Holy, Jaentsch, Liechti, Lubec, Baumann, Sitte and Luethi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Harald H. Sitte, aGFyYWxkLnNpdHRlQG1lZHVuaXdpZW4uYWMuYXQ=